Cigna (CI) to Reaffirm Outlook at Upcoming Investor/Analyst Meetings
Get Alerts CI Hot Sheet
Price: $270.02 -0.73%
EPS Growth %: -4.1%
Financial Fact:
Mail order pharmacy revenues: 762M
Today's EPS Names:
OCCI, PMCB, BRID, More
EPS Growth %: -4.1%
Financial Fact:
Mail order pharmacy revenues: 762M
Today's EPS Names:
OCCI, PMCB, BRID, More
Join SI Premium – FREE
Beginning on February 29, 2012 and through the balance of the week, Cigna (NYSE: CI) officials expect to participate in meetings and discussions with investors and analysts, including the Citi 2012 Global Health Care Conference. During these meetings, Company officials expect to reaffirm consolidated adjusted income from operations estimates for full year 2012, which remain in the range of $1.46 billion to $1.57 billion. The Company’s full year 2012 financial outlook assumes break-even results for the Company’s Guaranteed Minimum Death Benefits business (also known as “VADBe”) for full year 2012.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Citi reiterates buy rating on Advanced Energy Industries
- October Fed meeting hinges on this key economic data, Citi says
- BTCS completes SEC compliance steps for tokenized equity trading
Create E-mail Alert Related Categories
GuidanceRelated Entities
CitiSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share